Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.96% is 84% above its 5-year average of -182.32%, near the high end of its 5-year range (-668.43%–-13.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 81.33% above its 12-month average of -155.11%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.96%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-155.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-133.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-182.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-168.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-159.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-127.79%
CURRENT VS TTM AVG
+81.33%
CURRENT VS 3Y AVG
+78.30%
CURRENT VS 5Y AVG
+84.12%
CURRENT VS 10Y AVG
+82.79%
CURRENT VS 15Y AVG
+81.84%
CURRENT VS 20Y AVG
+77.34%
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
+15.08%
vs the sector median at left
Palisade Bio, Inc.
Market Cap
$261.24M
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-155.11%
3Y Avg
-133.47%
5Y Avg
-182.32%
Market Cap
$260.96M
Return on Invested Capital (ROIC)
-89.43%
TTM Avg
-77.88%
3Y Avg
-57.02%
5Y Avg
-48.01%
Market Cap
$259.85M
Return on Invested Capital (ROIC)
-37.61%
TTM Avg
-32.44%
3Y Avg
-54.09%
5Y Avg
-56.96%
Market Cap
$262.45M
Return on Invested Capital (ROIC)
-39.76%
TTM Avg
-63.41%
3Y Avg
-63.96%
5Y Avg
-51.83%
Market Cap
$265.39M
Return on Invested Capital (ROIC)
-42.92%
TTM Avg
-30.10%
3Y Avg
-80.25%
5Y Avg
-64.52%
Market Cap
$258.09M
Return on Invested Capital (ROIC)
-3.17%
TTM Avg
-4.70%
3Y Avg
-2.14%
5Y Avg
-2.73%
Market Cap
$265.41M
Return on Invested Capital (ROIC)
-15.00%
TTM Avg
-11.69%
3Y Avg
-3.29%
5Y Avg
-2.92%
Market Cap
$264.83M
Return on Invested Capital (ROIC)
-43.56%
TTM Avg
-66.27%
3Y Avg
-114.94%
5Y Avg
-104.61%
Market Cap
$267.03M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palisade Bio, Inc. (PALI) | $261.24M | -28.96% | -155.11% | -133.47% | -182.32% |
| AC Immune S.A. (ACIU)vs › | $260.96M | -89.43% | -77.88% | -57.02% | -48.01% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $259.85M | -37.61% | -32.44% | -54.09% | -56.96% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.45M | -39.76% | -63.41% | -63.96% | -51.83% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $265.39M | -42.92% | -30.10% | -80.25% | -64.52% |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.09M | -3.17% | -4.70% | -2.14% | -2.73% |
| OraSure Technologies, Inc. (OSUR)vs › | $265.41M | -15.00% | -11.69% | -3.29% | -2.92% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.83M | -43.56% | -66.27% | -114.94% | -104.61% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | -170.19% | -56.97% | -50.85% | -45.83% |
| Scribe Therapeutics Inc. (SCTX)vs › | $269.11M | N/A | N/A | N/A | N/A |
ROIC
-29.0%
ROE
-26.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.96% |
| 2026-03-31 | -20.75% |
| 2025-12-31 | -13.91% |
| 2025-09-30 | -309.15% |
| 2025-06-30 | -402.79% |
| 2025-03-31 | -249.33% |
| 2024-12-31 | -192.40% |
| 2024-09-30 | -212.35% |
| 2024-06-30 | -142.68% |
| 2024-03-31 | -137.87% |
| 2023-12-31 | -112.44% |
| 2023-09-30 | -93.78% |
| 2023-06-30 | -87.98% |
| 2023-03-31 | -102.18% |
| 2022-12-31 | -122.45% |
| 2022-09-30 | -121.33% |
| 2022-06-30 | -260.99% |
| 2022-03-31 | -668.43% |
| 2021-12-31 | -414.28% |
| 2021-09-30 | -295.02% |
| 2021-06-30 | -325.76% |
| 2020-06-30 | -51.59% |
| 2020-03-31 | -83.95% |
| 2019-12-31 | -160.10% |
| 2019-09-30 | -106.98% |
| 2019-06-30 | -337.22% |
| 2019-03-31 | -199.45% |
| 2018-12-31 | -124.52% |
| 2018-09-30 | -133.47% |
| 2018-06-30 | -109.00% |
| 2018-03-31 | -111.23% |
| 2017-12-31 | -107.58% |
| 2017-09-30 | -116.27% |
| 2017-06-30 | -173.46% |
| 2017-03-31 | -114.95% |
| 2016-12-31 | -108.75% |
| 2016-09-30 | -356.23% |
| 2016-06-30 | -185.26% |
| 2016-03-31 | -294.99% |
| 2015-12-31 | -145.48% |
| 2015-09-30 | -107.27% |
| 2015-06-30 | -77.67% |
| 2015-03-31 | -59.43% |
| 2014-12-31 | -65.63% |
| 2014-09-30 | -58.06% |
| 2014-06-30 | -49.31% |
| 2014-03-31 | -43.43% |
| 2013-12-31 | -77.12% |
| 2013-09-30 | -78.04% |
| 2013-06-30 | -95.10% |
| 2013-03-31 | -79.77% |
| 2012-12-31 | -145.22% |
| 2012-09-30 | -109.53% |
| 2012-06-30 | -427.23% |
| 2012-03-31 | -262.82% |
| 2011-12-31 | -782.64% |
| 2011-09-30 | -324.50% |
| 2011-06-30 | -203.56% |
| 2011-03-31 | -159.17% |
| 2010-12-31 | -193.33% |
| 2010-09-30 | -163.01% |
| 2010-06-30 | -115.11% |
| 2010-03-31 | -222.43% |
| 2009-12-31 | -723.55% |
| 2009-09-30 | 41.54% |
| 2009-06-30 | -20.29% |
| 2009-03-31 | 94.83% |
| 2008-09-30 | 25.19% |
| 2008-06-30 | 21.29% |
| 2008-03-31 | -5.99% |
| 2007-12-31 | -11.96% |
| 2007-09-30 | -148.66% |
| 2007-06-30 | -89.09% |
| 2007-03-31 | -57.54% |
